Curis Inc (CRIS)

NASDAQ
1.030
-0.040(-3.74%)
After Hours
1.050
+0.020(+1.942%)
- Real-time Data
  • Volume:
    10,396,425
  • Day's Range:
    1.020 - 1.120
  • 52 wk Range:
    0.700 - 9.040

CRIS Overview

Prev. Close
1.07
Day's Range
1.02-1.12
Revenue
10.52M
Open
1.05
52 wk Range
0.7-9.04
EPS
-0.56
Volume
10,396,425
Market Cap
94.39M
Dividend (Yield)
N/A
(N/A)
Average Vol. (3m)
3,230,814
P/E Ratio
-
Beta
2.95
1-Year Change
-86.62%
Shares Outstanding
91,645,369
Next Earnings Date
Aug 04, 2022
What is your sentiment on Curis?
or
Market is currently closed. Voting is open during market hours.

Curis Inc Analysis

Curis Inc Company Profile

Curis Inc Company Profile

Employees
60

Curis, Inc. is a biotechnology company. The Company is focused on the development of therapeutics for the treatment of cancer. Its clinical stage drug candidates are Emavusertib and CI-8993. Emavusertib is an orally available small molecule inhibitor of Interleukin-1 receptor-associated kinase 4 (IRAK4) which is undergoing testing in a Phase I open-label dose escalating clinical trial in patients with non-Hodgkin lymphomas. CI-8993 is a monoclonal antibody designed to antagonize the V-domain Ig suppressor of T cell activation (VISTA). Its pipeline also includes Fimepinostat, CA-170 and CA-327. Fimepinostat is a small molecule that inhibits the activity of histone deacetylase (HDAC), and phosphotidyl-inositol 3 kinase (PI3) enzymes. CA-170 is a small molecule antagonist of VISTA and PDL1. CA-327 is a small molecule antagonist of PDL1 and TIM3, which is a pre-IND stage oncology drug candidate.

Read More

Technical Summary

Type
5 Min
15 Min
Hourly
Daily
Monthly
Moving AveragesStrong SellSellNeutralBuyStrong Sell
Technical IndicatorsStrong SellStrong SellNeutralStrong BuyStrong Sell
SummaryStrong SellStrong SellNeutralStrong BuyStrong Sell
  • best idea in medical world....
    0
    • i bought .good company
      0
      • I bought.
        0
        • What do you think the price?
          0
        • Will be
          0
        • Well, the TP is very steep (7ish). Starting from -33% should position me in a positive way. Or, at least, I hope so! Cheers.
          0
      • This is like BTX, from 9-81 then went down
        2
        • Why is it to the moon today🤔
          1
          • where do you see curis in 6mths?
            0
            • Holy cow!! I bought a thousand of this at .68 in March on robinhood and forgot about it. What a nice surprise! Anyone think there may be more upside?
              3
              • Price target high 9$
                0
              • bro then send me bit of ur profit
                4
            • Expecting much more down side on a friday sell off, but nah not too bad so far
              0
              • What's do think guy for today?
                0
                • 9
                  2
                • stock guru9 is a far strech with what they just announced!
                  0
                • Cambron Eaton do you think it will continue to go down
                  0
              • Price target 9$
                0